EDMOND DE ROTHSCHILD HOLDING S.A. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
EDMOND DE ROTHSCHILD HOLDING S.A. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$3,878,000
-39.7%
86,250
-24.2%
0.11%
-50.9%
Q4 2020$6,431,000
+19.2%
113,7500.0%0.22%
+0.9%
Q3 2020$5,397,000
-19.5%
113,7500.0%0.21%
-22.5%
Q2 2020$6,707,000
+24.7%
113,7500.0%0.28%
-1.8%
Q1 2020$5,378,000
-21.8%
113,750
-0.1%
0.28%
+3.7%
Q4 2019$6,878,000
+8.2%
113,848
+7.3%
0.27%
+6.7%
Q3 2019$6,358,000
-8.0%
106,120
-1.3%
0.25%
-2.3%
Q2 2019$6,908,000
-38.6%
107,487
-22.5%
0.26%
-33.2%
Q1 2019$11,258,000
+46.1%
138,702
-2.7%
0.39%
+44.1%
Q4 2018$7,705,000
+6.4%
142,517
+1.5%
0.27%
+31.1%
Q3 2018$7,241,000
-1.4%
140,383
-20.3%
0.21%
-1.9%
Q2 2018$7,342,000
-13.3%
176,198
-8.3%
0.21%
-15.0%
Q1 2018$8,472,000
-29.9%
192,198
-20.0%
0.25%
-28.6%
Q4 2017$12,077,000
-1.0%
240,098
-0.2%
0.35%
-0.3%
Q3 2017$12,194,000
-0.3%
240,5030.0%0.35%
+0.6%
Q2 2017$12,235,000
+26.6%
240,5030.0%0.34%
+34.8%
Q1 2017$9,668,000
+0.8%
240,503
+19.9%
0.26%
-3.8%
Q4 2016$9,590,000
+45.1%
200,503
+11.1%
0.27%
+33.0%
Q3 2016$6,610,000
+41.9%
180,405
-9.8%
0.20%
+34.2%
Q2 2016$4,658,000
-42.5%
200,0000.0%0.15%
-42.2%
Q1 2016$8,100,000
-34.6%
200,0000.0%0.26%
-21.6%
Q4 2015$12,386,000200,0000.33%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,541,046$126,5576.89%
M28 Capital Management LP 126,300$4,513,9625.10%
Bellevue Group AG 9,511,900$339,955,3064.93%
Deep Track Capital, LP 2,834,069$101,289,6264.16%
BVF INC/IL 2,560,761$91,521,5983.35%
Sicart Associates LLC 210,698$7,530,3472.93%
Privium Fund Management B.V. 182,773$6,532,3072.19%
Camber Capital Management LP 1,925,000$68,8002.12%
Orbimed Advisors 2,124,500$75,929,6301.49%
SECTOR GAMMA AS 146,441$5,233,8011.27%
View complete list of IONIS PHARMACEUTICALS INC shareholders